Policy

Rival Lawyers Clash Over Fees After $2.8 Billion Blue Cross Settlement

By Intent.Health Team • September 03, 2026
rival lawyers clash over

What's Happening

Lawyers who represented hospitals and other healthcare providers in a major antitrust case against Blue Cross Blue Shield are now fighting one another over how future legal fees should be divided.

The dispute comes after a federal court approved a $2.8 billion nationwide settlement last year in a long-running case alleging that Blue Cross and some of its affiliates violated antitrust law by dividing the United States into exclusive territories and limiting competition. The healthcare providers argued that the arrangement increased the cost of insurance and reduced the payments they received from insurers. Blue Cross denied wrongdoing but agreed to the settlement and certain business changes. (Reuters)

The current fight is between the lawyers who represented the nationwide class and attorneys representing hospitals and health systems that opted out of the settlement and pursued their own lawsuits.

The class lawyers argue that those opt-out plaintiffs benefited from work they had already done and therefore should contribute part of any future settlements or judgments back to the class litigation team.

The opt-out lawyers strongly reject that argument.

The Original Blue Cross Antitrust Case

A lawsuit that began in 2012

The underlying litigation was filed in 2012 by hospitals and other healthcare providers.

The providers alleged that Blue Cross and certain affiliates had divided the country into exclusive territories where affiliated insurers agreed not to compete with one another. According to the allegations, that arrangement reduced competition, increased insurance costs and weakened reimbursement rates paid to healthcare providers. (Reuters)

Blue Cross denied wrongdoing.

Despite that denial, the insurer agreed to a nationwide settlement that resolved the class claims while also requiring certain business-related changes.

The settlement was approved in 2025

A federal court approved the $2.8 billion settlement in August 2025.

The settlement fund is expected to be distributed among as many as 3 million potential class members. (Reuters)

That made the case one of the most significant recent antitrust settlements involving the U.S. healthcare insurance industry.

But the settlement did not end every related lawsuit.

Many Healthcare Providers Opted Out

Major health systems pursued separate cases

Dozens of hospital systems and healthcare providers chose not to participate in the class settlement.

Those organizations include major systems such as:

The opt-out providers brought their own lawsuits against Blue Cross and sought the possibility of recovering greater damages than they would have received through the class settlement. (Reuters)

That created a second layer of litigation.

While the class case produced the $2.8 billion settlement, the individual plaintiffs continued pursuing their own claims.

Now the Lawyers Are Fighting Over the Opt-Out Cases

Class attorneys want a share of future recoveries

The lawyers who represented the nationwide provider class, led by Whatley Kallas, are asking the federal judge overseeing the litigation to establish a mechanism under which they would receive part of any future settlement or judgment obtained by the opt-out plaintiffs.

Their proposed arrangement would require a 12.5% set-aside from future recoveries obtained by the opt-outs. (Reuters)

The class attorneys argue that the opt-out cases benefited from the extensive work already performed in the nationwide litigation.

They say the competing lawsuits largely repeat allegations and legal theories developed during the class case.

They claim they spent hundreds of thousands of hours

Whatley Kallas told the court that the class lawyers have spent approximately 375,000 hours litigating the case.

Their argument is that the opt-out plaintiffs should not be able to use the results of that work without compensating the attorneys who performed it. (Reuters)

The class lawyers characterized the rival firms as effectively copying work developed during the original litigation.

The Opt-Out Lawyers Strongly Disagree

They call the demand “litigation piracy”

The lawyers representing the opt-out healthcare providers have rejected the proposed fee arrangement.

In a court filing, they described the class lawyers' demand as “litigation piracy” and argued that the request would improperly force providers who chose to leave the class settlement to pay additional fees. (Reuters)

They also accused the class lawyers of seeking to turn the court into a mechanism for guaranteeing themselves enormous future payouts.

Their position is that healthcare providers exercised a legal right to opt out of the class settlement and should therefore be free to pursue their own cases without paying a percentage of their recoveries to the class counsel.

The Fight Centers on the Right to Opt Out

Opting out is a fundamental feature of class actions

In a class action, certain plaintiffs may choose to exclude themselves from the settlement and pursue individual claims independently.

That option can be attractive to large organizations that believe their individual damages are potentially greater than the amount they would receive from a class settlement.

The legal fight in the Blue Cross case raises a difficult question:

Can lawyers who built the underlying class case later claim compensation from plaintiffs who chose not to participate in the settlement?

The class lawyers say their work created substantial value that benefited the opt-outs.

The opt-out lawyers say forcing them to pay a percentage of their recovery would effectively undermine their right to leave the class.

A Court Already Approved More Than $657 Million in Class Counsel Fees

The class lawyers have already received a substantial fee award.

The Alabama federal court approved a request for $657.1 million in attorney fees, representing 23.47% of the $2.8 billion settlement fund.

The court also approved at least $102 million in expenses. (Reuters)

That means the class lawyers already stand to receive a very large payment from the nationwide settlement.

Their current request concerns a separate pool of potential money: settlements or judgments later obtained by healthcare providers that opted out of the class action.

Why the Fee Dispute Matters

The eventual cost of the litigation could be much larger

The $2.8 billion settlement is not necessarily the end of the financial consequences for Blue Cross.

The opt-out plaintiffs continue to pursue their own cases, potentially seeking additional damages.

If those cases result in substantial settlements or judgments, the question of who receives what portion of that money could become extremely consequential.

A court-ordered percentage set aside for the class lawyers would effectively give them an economic interest in those later cases.

The Opt-Out Lawyers Warn of “Administrative Chaos”

Managing future fee disputes could become complicated

The attorneys representing the opt-out providers argue that creating a set-aside mechanism would generate additional disputes and administrative problems.

They warned that the court could face drawn-out battles over how much work was contributed by class counsel and how much was independently produced by the lawyers handling each opt-out case. (Reuters)

That could create a complex second litigation process layered on top of the original antitrust lawsuits.

For example, lawyers could end up arguing over:

Such disputes could continue long after the original antitrust claims are resolved.

The Healthcare Industry Is Directly Involved

This is not simply a dispute between law firms.

The underlying plaintiffs are hospitals, health systems and other healthcare providers, meaning the economic consequences of the case can directly affect healthcare organizations.

The original allegations concerned the relationship between insurers and providers, particularly the competitiveness of insurance markets and the reimbursement rates paid to healthcare organizations.

That makes the litigation relevant to the broader economics of the U.S. healthcare system.

The Case Highlights Tensions in Healthcare Insurance Markets

Provider-insurer negotiations are already contentious

Hospitals and health systems negotiate aggressively with insurers over reimbursement rates and network participation.

Large insurers, meanwhile, have significant bargaining power because of their large membership bases and extensive provider networks.

The original Blue Cross allegations went further, claiming that territorial restrictions among Blue Cross affiliates weakened competition.

The settlement and continuing lawsuits therefore reflect a much broader debate over competition, bargaining power and pricing in the U.S. health insurance market.

The Potential Recoveries Could Be Significant

The decision by major healthcare systems to pursue independent litigation indicates that some providers believe the value of their individual claims may exceed what they could obtain through the class settlement.

The class attorneys' request for a 12.5% set-aside also indicates that the future recoveries could be large enough to justify another major fee fight. (Reuters)

For hospitals, the stakes can be substantial because reimbursement economics directly affect operating margins, investment capacity and long-term financial planning.

A Broader Issue for Large Healthcare Organizations

Healthcare systems increasingly use litigation as a strategic tool

Large healthcare organizations have become sophisticated participants in antitrust, reimbursement and insurer disputes.

When class litigation does not fully capture the potential value of an organization's individual claims, major providers may choose to opt out and litigate independently.

That can produce greater potential recovery, but it also means greater legal expense and uncertainty.

The Blue Cross case illustrates both sides of that strategy.

Why This Matters

The latest dispute is important because it shows that a major healthcare settlement can create additional conflicts even after the headline settlement has been approved.

The original case produced a $2.8 billion settlement, but the decision by many major healthcare providers to opt out has created another layer of litigation involving potentially significant future recoveries.

At the center of that fight is a fundamental question about class-action litigation: when should lawyers who created the foundation for a nationwide case be compensated for benefits received by plaintiffs who later chose to pursue their own claims?

The answer could affect how future healthcare providers, insurers and law firms approach large class-action litigation.

Looking Ahead

The immediate issue is whether U.S. District Judge Anna Manasco will approve the class attorneys' proposed 12.5% set-aside from future opt-out recoveries.

The court will have to balance two competing considerations.

On one side is the class counsel argument that their years of work created significant value for the entire provider community.

On the other is the opt-out plaintiffs' argument that they have the legal right to pursue independent cases without being forced to pay fees to attorneys they did not retain for those individual lawsuits.

Whatever the court decides could influence how lawyers structure future class actions involving healthcare insurers and how large healthcare systems evaluate the benefits and costs of opting out.

Key Takeaways

What This Means for Healthcare Marketers

This story is less about marketing activity directly and more about a broader market-intelligence lesson for healthcare companies.

Large settlements, antitrust cases and insurer-provider disputes can materially change the financial and competitive environment in which healthcare organizations operate.

For healthcare marketers, those legal developments can be useful signals because they can precede changes in provider economics, payer relationships, reimbursement pressure and organizational strategy.

The bigger takeaway is that legal and financial events can be leading indicators of changes in healthcare buying behavior. A major insurer settlement may eventually influence how health systems negotiate contracts, allocate budgets or reassess vendors and services.